APLMW
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
May 16, 2:59 PM EST
BNTC
Price
$9.98
Change
+$0.49 (+5.16%)
Updated
May 20, 9:18 AM EST
Ad is loading...

APLMW vs BNTC

Header iconAPLMW vs BNTC Comparison
Open Charts APLMW vs BNTCBanner chart's image
Apollomics
Price$0.01
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Benitec Biopharma
Price$9.98
Change+$0.49 (+5.16%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
APLMW vs BNTC Comparison Chart

Loading...

VS
APLMW vs. BNTC commentary
May 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLMW is a Buy and BNTC is a Hold.

COMPARISON
Comparison
May 20, 2024
Stock price -- (APLMW: $0.01 vs. BNTC: $9.49)
Brand notoriety: APLMW and BNTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLMW: 234% vs. BNTC: 23%
Market capitalization -- APLMW: $0 vs. BNTC: $88.9M
APLMW [@Biotechnology] is valued at $0. BNTC’s [@Biotechnology] market capitalization is $88.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLMW’s FA Score shows that 1 FA rating(s) are green whileBNTC’s FA Score has 0 green FA rating(s).

  • APLMW’s FA Score: 1 green, 4 red.
  • BNTC’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLMW and BNTC are a bad buy in the long-term.

Price Growth

APLMW (@Biotechnology) experienced а -48.46% price change this week, while BNTC (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.55%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +63.17%.

Reported Earning Dates

BNTC is expected to report earnings on Sep 27, 2023.

Industries' Descriptions

@Biotechnology (+1.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for APLMW with price predictions.
OPEN
A.I.dvisor published
a Summary for BNTC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BNTC YTD gains are higher at: 193.808 vs. APLMW (-46.400).
APLMWBNTCAPLMW / BNTC
CapitalizationN/A88.9M-
EBITDAN/AN/A-
Gain YTD-46.400193.808-24%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BNTC: Fundamental Ratings
BNTC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASVGX10.870.03
+0.28%
American Century Small Cap Value R5
LSVVX14.630.04
+0.27%
LSV Conservative Value Equity
JACBX15.810.02
+0.13%
JHancock Mid Cap Growth I
AEGSX37.76N/A
N/A
Invesco EQV European Equity R6
CUSCX12.01-0.04
-0.33%
Cullen Small Cap Value C

APLMW and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLMW has been loosely correlated with VSTM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if APLMW jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLMW
1D Price
Change %
APLMW100%
N/A
VSTM - APLMW
37%
Loosely correlated
-5.19%
ELTX - APLMW
34%
Loosely correlated
+7.14%
ORMP - APLMW
33%
Poorly correlated
-1.29%
RVNC - APLMW
32%
Poorly correlated
-4.43%
GLYC - APLMW
32%
Poorly correlated
+6.51%
More

BNTC and

Correlation & Price change

A.I.dvisor tells us that BNTC and MLTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNTC and MLTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTC
1D Price
Change %
BNTC100%
+0.21%
MLTX - BNTC
30%
Poorly correlated
-2.72%
TCON - BNTC
25%
Poorly correlated
-6.54%
ORIC - BNTC
25%
Poorly correlated
+1.55%
APLMW - BNTC
24%
Poorly correlated
N/A
FATE - BNTC
24%
Poorly correlated
-5.80%
More